Following publication of the Review Article by Christabel K Cheung, Reginald Tucker-Seeley, Simon Davies, Megan Gilman, Kimberly A Miller, Gilberto Lopes, Gail D Betz, Thuli Katerere-Virima, Laura E Helbling, Bria N Thomas and Mark A Lewis, titled ‘A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy’, which appeared in Volume 17, Issue 28 of Future Oncology (Future Oncology[Lond.] 17[28], 3743–3756 [2020]; DOI: 10.2217/fon-2020-1213), it has been brought to our attention that the following text was omitted from the Financial & competing interests' disclosure:
“T Katerere-Virima was supported by the University of Maryland School of Social Work (UMSSW) Doctoral Research Assistant program; LE Helbling was supported by the UMSSW Research Assistant Scholars program. BN Thomas was supported in part by the University of Maryland School of Medicine Nathan Schnaper Intern Program in Translational Cancer Research. M Gilman was supported by the Memorial Sloan Kettering Cancer Center Core Grant (P30 CA008748)”.
Additionally, the following sentence: “This worsening trend is especially observed among non-Hispanic and black individuals, who comprise 75% of racial and ethnic minority AYAs [8,10,11]” has been corrected as follows: “This worsening trend is especially observed among non-Hispanic and Black individuals, who comprise 75% of racial/ethnic minority AYAs with lower five-year cancer survival rates [8,10,11]”.
The authors and editors of Future Oncology would like to sincerely apologise for any confusion or inconvenience this may have caused our readers.
